Contact
Biography
As an NRF fellow, I am currently focusing on controlling the foreign body response related to macro-devices used for cellular therapeutic delivery in diabetes treatment. This research, a collaborative effort between MIT and the University of Nottingham, represents a cutting-edge frontier in biomedical engineering. I'm excited to contribute my expertise to this innovative field.
Prior to this, I worked as a consultant in the life sciences sector, advising on a range of projects spanning clinical research and biotechnology. This role further honed my skills in applying scientific innovation to real-world challenges. My previous research experience includes a significant stint at the University of Cambridge, where I joined in 2020. There, I contributed to virology research, focusing notably on SARS-CoV-2 evolution and the impact of mutations on viral fitness and immune escape. My work led to the identification of the British Alpha variant.
Before Cambridge, I completed my PhD at the University of Nottingham (2015-2019) under the guidance of Professors Paul Williams, Morgan Alexander, and Andrew Hook. My doctoral research focused on discovering acrylate polymers resistant to bacterial attachment and uncovering the biological mechanisms driving these interactions. These experiences at Nottingham and Cambridge have deepened my passion for research that has a meaningful impact on society.
Expertise Summary
Cell therapies for type I diabetes, novel biomaterial development, characterize immune responses to bio-materials, in vivo testing various diabetes models, complex hydrogel manufacture and system design